Julio Delgado

idibaps

H指数:58

被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The European CAR-T map—Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies

欧洲CAR-T地图——当前状况和未来方向：改善血液恶性肿瘤CAR T细胞疗法的可及性

HemaSphere

IF14.6

2026-03-050

OAAI

Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee

CAR T细胞治疗的运营负担与碎片化实施：来自GoCART联盟和JACIE质量经理委员会的多国调查的见解

HemaSphere

IF14.6

2025-10-270

OAAI

CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia

CD19 CAR T细胞疗法在Richter转化中的研究：欧洲慢性淋巴细胞白血病研究倡议进行的 multicentre 回顾性分析

Journal of Cellular and Molecular Medicine

IF4.2

2025-10-220

OAAI

Ofrat Beyar-Katz; Ohad Benjamini; Julio Delgado; Marco Ruella; Ron Ram; Sigal Grisariu; Andrea Visentin; Elisabeth Vandenberghe; Massimo Gentile; Abraham Avigdor; Avichai Shimoni; Roni Shouval; Ronit Marcus; Stephen J. Schuster; Valentin Ortiz-Maldonado; Guido Ghilardi; Luca Paruzzo; Tsila Zuckerman; Tamar Tadmor; Riva Fineman; Odelia Amit; Nuria Martinez-Cibrian; Giulia Gabrielli; Batia Avni; Eva Minga; Noga Shem-Tov; Lydia Scarfo; Ronit Yerushalmi; Arnon Nagler; Ronit Leiba; Ivetta Danylesko; Kostas Stamatopoulos; Thomas Chatzikonstantinou; Paolo Ghia; Yair Herishanu

Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

欧洲接受CAR T细胞疗法治疗的血液恶性肿瘤患者的患者报告结局

Blood Advances

IF7.1

2025-09-260

OAAI

Elise R.A. Pennings; Anne M. Spanjaart; Frederick W. Thielen; Simone Oerlemans; Anna Fleischer; Carmen Sanges; Maria Gomes Da Silva; Yolanda Cabrerizo; Pacôme Lecot; Lutgart Roux-Opstaele; Caroline Dreuillet; Eglys Gonzalez-Marcano; Olga Millán; Ulrich Jaeger; Julio Delgado; Maik Luu; Barbara Huber; Margot Lorrain; Mariana Pina; Andreas Kremer; Natacha Bolaños; Solène Clavreul; Samantha Nier; Roberto D.K. Liu; Birgit I. Lissenberg-Witte; Sébastien Anguille; Marie Robin; Emma C. Morris; Anna Sureda; Marie Préau; Myriam Pannard; Geertruida H. De Bock; Scott S. Wagers; Hélène Negre; Delphine Maucort-Boulch; Michael Hudecek; Carin A. Uyl-de Groot; Marie José Kersten

Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma

Varnimcabtagene autoleucel学术性抗CD19嵌合抗原受体T细胞产品在治疗复发/难治性滤泡性淋巴瘤中的有效性与安全性

HemaSphere

IF14.6

2025-09-110

OAAI

Núria Martínez-Cibrián; Valentín Ortiz-Maldonado; Marta Español-Rego; Leticia Alserawan; Sergio Navarro; Nil Albiol; Miquel Lozano; Paola Charry; Laura Magnano; Andrea Rivero; Juan G. Correa; Pablo Mozas; Albert Cortés-Bullich; Carlos Jiménez-Vicente; Eva Giné; Mercedes Montoro-Lorite; Carla Ramos; Pilar Ayora; Hugo Calderón; María Sánchez-Castañón; Daniel Benítez-Ribas; Juan J. Mata-Molanes; Kelly Rojas; Xavier Setoaín; Sonia Rodríguez; Adrià Murias; Pau Alcubilla; Sara Varea; Eulalia Olesti; Mireia Bachiller; María Calvo-Orteu; Carla Sans-Pola; Joaquín Sáez-Peñataro; Carlos Fernández de Larrea; Armando López-Guillermo; E. Azucena González-Navarro; Manel Juan; Julio Delgado

CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis

CD19 CAR T细胞疗法治疗原发性纵隔大B细胞淋巴瘤：一项CIBMTR分析

American Journal of Hematology

IF9.9

2025-08-110

PRE

Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations

细胞和基因治疗产品去中心化制造的质量管理体系实施 - 技术与监管考量

Frontiers in Medicine

IF3

2025-08-070

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias

一种靶向CD84的新型嵌合抗原受体T细胞疗法，用于治疗急性髓系和T细胞淋巴母细胞白血病

Leukemia

IF13.4

2025-08-060

OAAI

Lorena Pérez-Amill; Mercedes Armand-Ugón; Maria Val-Casals; Beatriz Martín-Herreros; José R. Álamo; Sergio Peña; Gerard Frigola; Ane Altuna; Claudio Santos; Francesca Guijarro; Alfredo Minguela; Àlex Bataller; Berta Casanovas-Albertí; Mireia Uribe-Herranz; Irene Navarro; Manuel Guerreiro; Diego Sánchez-Martínez; Néstor Tirado; Talía Velasco-Hernandez; Pablo Menéndez; Antonio Martínez; Montse Rovira; Dolors Colomer; E. Azucena González-Navarro; Jordi Esteve; Álvaro Urbano-Ispizua; Pau Montesinos; Julio Delgado; Manel Juan; Nela Klein-González

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia

IF13.4

2025-06-300

OAAI

Ferran Nadeu; Shimin Shuai; Guillem Clot; Laura K. Hilton; Ander Diaz-Navarro; Silvia Martín; Romina Royo; Tycho Baumann; Marta Kulis; Irene López-Oreja; Manuel Cossio; Junyan Lu; Viktor Ljungström; Emma Young; Karla Plevova; Binyamin A. Knisbacher; Ziao Lin; Cynthia K. Hahn; Pablo Bousquets; Miguel Alcoceba; Marcos González; Enrique Colado; Ángel R. Payer; Marta Aymerich; María J. Terol; Alfredo Rivas-Delgado; Anna Enjuanes; Sílvia Ruiz-Gaspà; Thomas Chatzikonstantinou; Daniel Hägerstrand; Cecilia Jylhä; Aron Skaftason; Larry Mansouri; Kamila Stranska; Michael Doubek; Ellen J. van Gastel-Mol; Zadie Davis; Renata Walewska; Lydia Scarfò; Livio Trentin; Andrea Visentin; Sameer A. Parikh; Kari G. Rabe; Riccardo Moia; Marine Armand; Davide Rossi; Frederic Davi; Gianluca Gaidano; Neil E. Kay; Tait D. Shanafelt; Paolo Ghia; David Oscier; Anton W. Langerak; Sílvia Beà; Armando López-Guillermo; Donna Neuberg; Catherine J. Wu; Gad Getz; Sarka Pospisilova; Kostas Stamatopoulos; Richard Rosenquist; Wolfgang Huber; Thorsten Zenz; Dolors Colomer; José I. Martín-Subero; Julio Delgado; Ryan D. Morin; Lincoln D. Stein; Xose S. Puente; Elías Campo

European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring

欧洲CAR T细胞分析方法的调查：从apheresis到输注后免疫监测

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-04-240

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia

慢性淋巴细胞白血病中基因组改变与血清单克隆蛋白的关系

CELLS

IF5.2

2024-11-071

OAAI

Outpatient Reinfusion of CAR-T Cesnicabtagene Autoleucel (ARI0002h) in Multiple Myeloma Is Feasible and Safe

CAR-T细胞Cesnicabtagene Autoleucel（ARI0002h）在多发性骨髓瘤中的门诊回输是可行且安全的。

BLOOD

IF23.1

2024-11-050

PRE

Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias

CD19-CARpos和CARneg T细胞的整合单细胞多组学提示b细胞肿瘤中免疫治疗反应的驱动因素

CELL REPORTS MEDICINE

IF10.6

2024-11-010

OAAI

Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy

预测早期CLL疾病进展的风险评分: IGHV子集 #2的比较分析和有用性，以提高其准确性

CANCER

IF5.1

2024-09-120

PRE

CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD

难治性MOGAD患者的CAR T细胞CD19-Directed

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2024-09-014

OAAI

Chimeric Antigen Receptor T-Cell Postinfusion Fever: Infection Profile, Clinical Parameters, and Biomarkers Trends to Assist Antibiotic Stewardship

嵌合抗原受体T细胞输注后发热: 感染概况，临床参数和生物标志物趋势，以协助抗生素管理

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-07-112

OAAI

Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

在先前未经治疗的慢性淋巴细胞白血病 (CLL) 患者中，依鲁替尼继之以ofatumumab巩固: 西班牙CLL组 (GELLC) 的GELLC-7试验

ECLINICALMEDICINE

IF10

2024-07-010

OAAI

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

学术BCMA-CART ARI0002h治疗难治性多发性骨髓瘤的疗效和安全性的生物标志物

CLINICAL CANCER RESEARCH

IF10.2

2024-03-114

PRE

Oliver-Caldes, Aina; Espanol-Rego, Marta; Zabaleta, Aintzane; Gonzalez-Calle, Veronica; Navarro-Velazquez, Sergio; Inoges, Susana; de Cerio, Ascension Lopez-Diaz; Cabanas, Valentin; Lopez-Munoz, Nieves; Rodriguez-Otero, Paula; Reguera, Juan Luis; Moreno, David F.; Martinez-Cibrian, Nuria; Lopez-Corral, Lucia; Perez-Amill, Lorena; Martin-Antonio, Beatriz; Rosinol, Laura; Cid, Joan; Tovar, Natalia; Saez-Penataro, Joaquin; Lopez-Parra, Miriam; Olesti, Eulalia; Guillen, Elena; Varea, Sara; Rodriguez-Lobato, Luis Gerardo; Battram, Anthony M.; Gonzalez, Marta Sonia; Sanchez-Salinas, Andres; Gonzalez-Navarro, Azucena; Ortiz-Maldonado, Valentin; Delgado, Julio; Prosper, Felipe; Juan, Manel; Martinez-Lopez, Joaquin; Moraleda, Jose M.; Mateos, Maria Victoria; Urbano-Ispizua, Alvaro; Paiva, Bruno; Pascal, Mariona; de Larrea, Carlos Fernandez

Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle

淋巴细胞耗竭-嵌合抗原受体T细胞治疗周期的重要但被低估的部分

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-12-2229

OAAI

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

IGLV3-21R110突变对未接受过治疗的慢性淋巴细胞白血病患者的预后价值

BLOOD ADVANCES

IF7.1

2023-12-123

OAAI

Syrykh, Charlotte; Pons-Brun, Berta; Russinol, Nuria; Playa-Albinyana, Heribert; Baumann, Tycho; Duran-Ferrer, Marti; Kulis, Marta; Carbo-Meix, Anna; Mozas, Pablo; Alcoceba, Miguel; Gonzalez, Marcos; Navarro-Bailon, Almudena; Colado, Enrique; Payer, Angel R.; Aymerich, Marta; Terol, Maria J.; Lu, Junyan; Knisbacher, Binyamin A.; Hahn, Cynthia K.; Ruiz-Gaspa, Silvia; Enjuanes, Anna; Wu, Catherine J.; Getz, Gad; Zenz, Thorsten; Lopez-Guillermo, Armando; Martin-Subero, Jose I.; Colomer, Dolors; Delgado, Julio; Campo, Elia; Nadeu, Ferran

Julio Delgado

个人简介

教育背景

工作经历

荣誉奖项

研究方向